Melanoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Melanoma Genomics

- Cancer PHGKB -

What's New

Last Posted: May 03, 2018

---

• Breast Cancer Genes a Real Risk for Men, Too  
  R Preidt, Health Day, Apr 26, 2018
• Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma.  
  Sener Ebru et al. Pathology, research and practice 2017 May 213(5) 522-530
• National Distribution of Cancer Genetic Testing in the United States- Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer  
  K Childers et al, JAMA Onc, Apr 26, 2018
• Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.  
  Ko Jennifer S et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 Jul 26(7) 1107-1113
• Malignant Abnormalities in Male BRCA Mutation Carriers Results From a Prospectively Screened Cohort  
  R Mano et al, JAMA Oncology, Apr 2018
• Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.  
  Chowell Diego et al. Science (New York, N.Y.) 2018 359(6375) 582-587
• Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology  
  J Marquart et al, JAMA Oncology, Apr 17, 2018
• Major hereditary gastrointestinal cancer syndromes: a narrative review.  
  Chintalacheruvu Lakshmi Manogna et al. Journal of gastrointestinal and liver diseases : JGLD 2017 Jun 26(2) 157-163
• Pathogenic Germline Variants in 10,389 Adult Cancers.  
  Huang Kuan-Lin et al. Cell 2018 Apr 173(2) 355-370.e14
• High Expectations for Immunotherapy in GI Cancers- Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.  
  A Weintraub, Cure Magazine, Mar 2018